Yahoo Finance UK: Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
Recent performance context for Grifols Grifols (BME:GRF) has drawn investor attention after a mixed run, with a modest 1 day gain, a negative move over the past week and month, and a deeper decline ...
Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
Seeking Alpha: Grifols: Upside After A Smashing Q1 2023 - I Say 'Buy'
My first take on Grifols, S.A. (GRFS) was poorly timed. The company declined immediately after my piece, and my initial stake went down a bit. I did, however, buy some more, and this balancing of ...
BARCELONA, Feb 26 (Reuters) - Spanish drugmaker Grifols (GRLS.MC), opens new tab reported on Wednesday a net profit of 157 million euros ($165.02 million) for 2024 on revenues of 7.21 billion euros, ...
Reuters: Grifols minority shareholders team up to ask for a board seat
MADRID, Sept 20 (Reuters) - Three investment funds with holdings in Spanish drugmaker Grifols (GRLS.MC), opens new tab have teamed up to ask to fill a vacant seat on the company's board, they said in ...
Hello, everyone. My name is Danny Segarra, and myself as the Head of Investor Relations and Sustained and Vice President, Grifols. Welcome to our review of the company's Business Results for the First ...